Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bethpage, NY
NPI
1750566402
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4250 Hempstead Tpke, Suite 23
Bethpage, NY, 11714
Phone (516) 520-0001
Groups this clinician bills Medicare through
Medicare paid, 2024
$376K
4,259 services
Medicare patients, 2024
1,265
Average age 74
Drug cost, 2024
$6.6M
8,507 prescriptions
Company payments, 2025
$3,869
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Craig D Perlman was code 99214 (office e&m - established), 1,423 times for 887 patients. In total Craig D Perlman billed 4,259 services in 23 codes, and Medicare paid $376K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,423 | 887 | $105.77 | $151K |
| 95251 Test - Miscellaneous | Office | 703 | 433 | $28.35 | $20K |
| 99232 Hospital E&M - Subsequent | Facility | 471 | 179 | $65.62 | $31K |
| 76536 Ultrasound - Nonspecific | Office | 313 | 296 | $88.70 | $28K |
| 95250 Test - Miscellaneous | Office | 257 | 202 | $129.19 | $33K |
| 99223 Hospital E&M - Initial | Facility | 235 | 200 | $144.10 | $34K |
| 95923 Electrical Nerve Conductivity | Office | 176 | 167 | $104.59 | $18K |
| 99204 Office E&M - New | Office | 175 | 175 | $140.02 | $25K |
| 95921 Electrical Nerve Conductivity | Office | 171 | 163 | $75.09 | $13K |
| 95249 Test - Miscellaneous | Office | 111 | 102 | $56.04 | $6,220 |
| 99222 Hospital E&M - Initial | Facility | 84 | 82 | $109.38 | $9,188 |
| 10005 Other Organ Systems | Office | 37 | 37 | $116.78 | $4,321 |
| 94690 Pulmonary Function Testing | Office | 28 | 28 | $43.18 | $1,209 |
| 96372 Injection Administration | Office | 24 | 16 | $12.22 | $293 |
| 10006 Other Organ Systems | Office | 15 | 13 | $51.53 | $773 |
By year: 2022 $488K for 4,969 services; 2023 $439K for 4,607 services; 2024 $376K for 4,259 services.
Medicare prescription drug claims, 2024
In 2024, the drug Craig D Perlman prescribed most often to Medicare patients was Levothyroxine Sodium, with 772 prescriptions and refills. In total Craig D Perlman wrote 8,507 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 772 | 2,150 | 210 | $12K |
| Metformin Hcl Er Metformin Hcl | 573 | 1,632 | 181 | $8,726 |
| Mounjaro Tirzepatide | 572 | 1,107 | 146 | $1.2M |
| Jardiance Empagliflozin | 556 | 1,308 | 157 | $751K |
| Ozempic Semaglutide | 552 | 1,265 | 158 | $1.2M |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 387 | 1,108 | 162 | $40K |
| Trulicity Dulaglutide | 352 | 711 | 100 | $689K |
| Metformin Hcl Generic | 285 | 832 | 94 | $3,083 |
| Farxiga Dapagliflozin Propanediol | 273 | 685 | 79 | $367K |
| Synthroid Levothyroxine Sodium | 245 | 674 | 63 | $19K |
| Tresiba Flextouch U-100 Insulin Degludec | 235 | 617 | 86 | $169K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 216 | 603 | 80 | $38K |
| Methimazole Generic | 166 | 477 | 48 | $1,690 |
| Tresiba Flextouch U-200 Insulin Degludec | 143 | 387 | 46 | $189K |
| Novolog Flexpen Insulin Aspart | 139 | 372 | 57 | $54K |
Brand drugs: 4,921 claims; generic drugs: 2,822 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Craig D Perlman $3,869 ($3,869 in general payments such as food, travel and fees) from 31 companies. The largest payer was Dexcom, Inc. with $514.
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. DXCM | 11 | $514 |
| Xeris Pharmaceuticals, Inc. | 16 | $321 |
| Lilly USA, LLC LLY | 15 | $313 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $249 |
| Novo Nordisk Inc NVO | 10 | $220 |
| Madrigal Pharmaceuticals MDGL | 4 | $210 |
| IBSA Pharma Inc. | 2 | $198 |
| CeQur Corporation | 1 | $178 |
| Abbott Laboratories ABT | 8 | $164 |
| Mannkind Corporation MNKD | 5 | $149 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.